STAMBP and autoimmune uveitis: In experimental autoimmune uveitis, α-MSH treatment suppresses the intraocular inflammation, restores RPE anti-inflammatory activity, and promotes the induction of immune tolerance to retinal antigens, along with preserving the structure of the retina [14,35,44].